UNICREDIT BANK/CALL/SARTORIUS STEDIM BIO/300/0.01/19.03.25 Stock

Warrant

F217T

DE000HD40UA8

Market Closed - Euronext Paris 12:30:02 2024-05-17 pm EDT
0.09 EUR -25.00% Intraday chart for UNICREDIT BANK/CALL/SARTORIUS STEDIM BIO/300/0.01/19.03.25
Current month-18.18%
1 month-70.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 0.09 -25.00%
24-05-16 0.12 -14.29%
24-05-15 0.14 +16.67%
24-05-14 0.12 +20.00%
24-05-13 0.1 -9.09%

Real-time Euronext Paris

Last update May 17, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer UniCredit UniCredit
F217T
ISINDE000HD40UA8
Date issued 2024-03-21
Strike 300
Maturity 2025-03-19 (304 Days)
Parity 100 : 1
Emission price-
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.46
Lowest since issue 0.09
Delta0.24x
Omega 4.912
Premium57.27x
Gearing20.72x
Moneyness 0.6560
Difference Strike 103.2
Difference Strike %+34.40%
Spread 0.01
Spread %10.00%
Theoretical value 0.0950
Implied Volatility 45.94 %
Total Loss Probability 87.21 %
Intrinsic value 0.000000
Present value 0.0950
Break even 309.50 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
196.8 EUR
Average target price
250.1 EUR
Spread / Average Target
+27.07%
Consensus
  1. Stock Market
  2. Warrants
  3. F217T Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW